Michał Oleksiejczuk has received his full sanctions.
After a positive drug test last year, USADA suspended the UFC light heavyweight prospect for one year, the UFC’s anti-doping partner announced Tuesday.
Oleksiejczuk failed an in-competition drug test in relation to his UFC 219 bout against Khalil Rountree on Dec. 30. He tested positive for clomiphene, an anti-estrogen agent prohibited at all times by WADA, and also the same substance Jon Jones and Brock Lesnar failed for at UFC 200. Oleksiejczuk initially won his UFC debut by decision, but the bout was later overturned to a no contest due to the positive test.
Oleksiejczuk was already suspended one year by the Nevada State Athletic Commission (NAC) in March. Both suspensions will run concurrently, ending at the same time. His period of ineligibility began on Dec. 30, 2017; therefore, he’ll be able to return to the cage on Dec. 30, 2018.
Before the no contest against Rountree, Oleksiejczuk (12-2, 1 NC) was riding a nine-fight winning streak outside the UFC, with eight of those wins ending inside the distance.